LAMP
Registro de marca em vigor (Madri)
Marca Nominativa depositada no INPI em
04/08/2020 por CytoDyn Inc.,
processo nº 501569551, nas classes 05, 42, 44.
Registro em vigor até 04/08/2030.
| Número do processo | 501569551 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 04/08/2020 |
|---|
| Data da concessão | 09/11/2021 |
|---|
| Vigência até | 04/08/2030 |
|---|
| Titular | CytoDyn Inc. |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · US |
Classes e especificação
Therapeutic preparations; therapeutic preparations, namely, antibodies for use in targeting C-C chemokine receptor type [CCR5] cell receptor; therapeutic preparations for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.;
Scientific research consulting services; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis; medical research and analysis services; medical research and analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis.;
Providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, non alcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 via a website (Terms too vague in the opinion of the International Bureau ? Rule 13 (2) (b) of the Regulations).;